Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

AMREP Corporation Reports Sharp Decline in Earnings per Share for Q3 2024

Elaine Mendonca by Elaine Mendonca
March 8, 2024
in Breaking News
0
Investings on laptop and finances
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

AMREP Corporation disclosed its financial performance for the third quarter of fiscal 2024 on March 8, 2024. The company reported a net income of $92,000, or $0.02 per diluted share, which is a sharp decrease from $16,574,000, or $3.12 per diluted share, in the same quarter of the prior year. For the first nine months of 2024, AMREP recorded a net income of $2,546,000, or $0.48 per diluted share, as opposed to $22,107,000, or $4.17 per diluted share, in the corresponding period of 2023.

The earnings per share for AMREP plummeted significantly, while sales saw a notable increase during the specified time frames.

AXR Stock Performance Review: Potential Positive Momentum Despite Minor Decline

On March 8, 2024, AXR stock had a mixed performance as it closed at $22.50, which was a decrease of $0.34 or 1.49% from the previous market close. However, in after-hours trading, the stock rose by $0.50, indicating some potential positive momentum.

One key indicator of AXR’s performance is that it is currently trading near the top of its 52-week range and above its 200-day simple moving average. This suggests that the stock has been performing well over a longer period of time, which may be a positive sign for investors.

The slight drop in price during regular trading hours could be attributed to various factors such as market volatility, news events, or changes in investor sentiment. However, the increase in after-hours trading could indicate that some investors see potential value in the stock at its current price.

It is important for investors to consider all relevant factors when evaluating a stock’s performance, including technical indicators, market trends, and company fundamentals. While past performance is not indicative of future results, the current price momentum of AXR may be worth monitoring for those interested in the stock.

AXR Stock Performance: Revenue Decline but Net Income Increase – March 8, 2024 Data Analysis

On March 8, 2024, AXR stock experienced mixed performances based on the financial data provided. The total revenue for the company was $48.68 million over the past year, with a significant decrease of 22.09% compared to the previous year. In the second quarter, the total revenue dropped further to $8.85 million, marking a 13.95% decrease from the previous quarter.

Despite the decline in total revenue, AXR managed to increase its net income over the past year. The net income for the company was reported at $21.79 million, showing a notable 37.37% increase compared to the previous year. However, in the second quarter, the net income decreased to $1.11 million, reflecting a 17.68% drop from the previous quarter.

Earnings per share (EPS) also showed a mixed trend for AXR stock. The EPS for the past year was $4.11, indicating an impressive 86.19% increase from the previous year. However, in the second quarter, the EPS decreased to $0.21, marking a 17.92% decline from the previous quarter.

Tags: AXR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Stock Market Today (1)

Legend Biotech Reports Strong Financial Results for Q4 2023

Business management and administrations

The Power of Intelligent Business Process Management Suites: How Automation is Revolutionizing Organizational Efficiency

Finance_Investment (2)

Analyst Reiterates Buy Rating on FrancoNevada with Adjusted Price Target

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com